Record #57249
Upregulating hsa-miR-128a Increased the Effects of Pembrolizumab on Laryngeal Cancer Cells via the p53 Pathway
Publisher
Original paper date
Mar 19, 2021
Original DOI
Citation lifecycle
How this paper is being cited
Pre-retraction
2
Same day
1
Post-retraction
2
% post-retraction
40.0%
~0.7 citations/yr before retraction · ~0.7 citations/yr after
— citing papers
Who is still citing this work
Loading…